Alterity Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $2,118 | $690 | $1,900 |
Gross Profit | 2,044 | 652 | 1,826 |
EBITDA | -14,615 | -4,227 | -8,333 |
EBIT | -14,688 | -4,233 | -8,407 |
Net Income | -12,616 | -4,113 | -6,507 |
Net Change In Cash | 2,118 | 690 | 1,900 |
Free Cash Flow | -5,714 | -2,577 | -4,865 |
Cash | 12,638 | 8,241 | 12,320 |
Basic Shares | 7,960 | 4,794,472 | 4,172 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $4,019 | $3,916 | $5,123 | $4,339 |
Gross Profit | 3,804 | 3,631 | 4,758 | 3,979 |
EBITDA | -19,571 | -17,514 | -17,392 | -19,360 |
EBIT | -19,606 | -17,616 | -17,446 | -19,435 |
Net Income | -19,123 | -13,806 | -12,847 | -15,309 |
Net Change In Cash | 4,019 | 3,916 | 5,123 | 4,339 |
Free Cash Flow | -12,611 | -20,043 | -12,426 | -17,340 |
Cash | 12,638 | 15,773 | 34,806 | 28,115 |
Basic Shares | 6,081 | 4,046 | 4,009 | 2,828 |
Earnings Calls
| Quarter | EPS |
|---|---|
2023-03-31 | $0 |
2022-12-31 | $0 |
2022-09-30 | $0 |
2022-06-30 | -$0.23 |
